Skip to content

Respiratory Disorders or Diseases

The following section lists major devlopment along the innovative drug route.

Click horizontal tabs above for more information.

Company *product

IND

Phase I

Phase II

Phase III

Regend Therapeutics
*REGEND001
*Airway basal cells 
没找到官网,需补充。

Regend Therapeutics
*REGEND007
*Airway basal cells 
没找到官网,需补充。

Yuanpin Cell Biotech
*HAMSC
*Severe COPD

Shandong Qilu Cell Therapy
*YFQLXB‑UC01

YouSai Life Sciences
*MSC

Company *product

IND

Phase I

Phase II

Phase III

Regend Therapeutics
*REGEND001
*Airway basal cells

Regend Therapeutics
*REGEND007
*Airway basal cells

Laifu Medical Tech
*官网失效?

Shunxi Regenerative Medicine
*SCM-181

VCAN Bio
*VUM02

Company *product

IND

Phase I

Phase II

Phase III

Nuwacell Biotech
*NCR101

Company *product

IND

Phase I

Phase II

Phase III

Yuanpin Cell Biotech
*HAMSC

Shanghai Quansheng Bio
*VUM02

VCAN Biotech
*VUM02
https://www.vcanbio.com/business-xbzl

Shandong Qilu Cell Therapy
*YFQLXB‑UC01

YouSai Life Sciences
*MSC

Company *product

IND

Phase I

Phase II

Phase III

Regend Therapeutics
*REGEND001

End of Section

The following section lists major development along the innovatie biomedical technology route.

Click horizontal tabs above for more information.

Hospitals *biomedical tech

Clinical Study

Approved

Shanghai Pulmonary Hospital (Shanghai )
*MSC
*Acutely deteriorated

Hospitals *biomedical tech

Clinical Study

Approved

Beijing You-An Hospital, Capital Medical University (Beijing)
*MSC
https://www.bjyayy.com.cn/Html/News/Main/515.html

Hospitals *biomedical tech

Clinical Study

Approved

???
*cell?

End of Section